ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

ETF Overview

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

Key Stats

• Today's Range: $28.14 to $28.68
• 50-Day Range: $23.59 to $31.05
• 52-Week Range: $22.33 to $42.73
• Volume: 5,737 shs
• Average Volume: 11,804 shs
• Market Capitalization: $81.71 million
• Assets Under Management: $81.02 million
• Dividend Yield: 4.08%
• Net Expense Ratio: 0.50%
• Aggregate Rating: Moderate Buy

SBIO ETF - Frequently Asked Questions

How have SBIO shares performed this year?

ALPS Medical Breakthroughs ETF's stock was trading at $33.03 at the beginning of the year. Since then, SBIO stock has decreased by 13.2% and is now trading at $28.67.
View the best growth stocks for 2025 here.

Who are ALPS Medical Breakthroughs ETF's major shareholders?

Top institutional investors of ALPS Medical Breakthroughs ETF include Phoenix Financial Ltd. (50.87%), DAVENPORT & Co LLC (25.98%), Jones Financial Companies Lllp (0.96%) and NTV Asset Management LLC (0.94%).

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Waste Connections (WCN), American Water Works (AWK), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Fund Details

• Issuer: ALPS
• Fund Name: ALPS Medical Breakthroughs ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:SBIO
• Inception Date: 12/31/2014
• Fund Manager: Ryan Mischker, Andrew Hicks
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: S-Network Medical Breakthroughs Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 104

Fund Statistics

• Assets Under Management: $81.02 million
• Average Daily Volume: $14,236.10
• Discount/Premium: -0.01%

Administrator, Advisor and Custodian

• Administrator: ALPS Fund Services, Inc.
• Advisor: ALPS Advisors, Inc.
• Custodian: State Street Bank and Trust Company
• Distributor: ALPS Portfolio Solutions Distributor, Inc.
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: GTS

Options

• Optionable: N/A
• Short Interest: 3,500 shs

Miscellaneous

• Outstanding Shares: 2,850,000
• Beta: 0.77
• Creation Unit: 50,000
• Creation Fee: $500.00